Sallie R. Permar

NIH Rank #706

NIH Funding · FY2024

Total Funding

$6.6M

Fiscal year 2024

Grants Awarded

Active NIH grants

National Rank

#706

Among 57,894 PIs

First NIH Award

2024

Year of first funding

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $6.6M across 10 grants · National rank #706.

Sallie R. Permar's NIH grant portfolio, ranked by award amount.

5K12HD000850-40K12
Pediatric Scientist Development Program
Weill Cornell Medicine
$1.5M
award amount
5R01AI161008-04R01
Early life B cell responses and inflammation following SARS-CoV-2 infection
Weill Cornell Medicine
$852.9K
award amount
5R01AI162245-04R01
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
Weill Cornell Medicine
$828.2K
award amount
5R01AI173333-02R01
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
Weill Cornell Medicine
$822.3K
award amount
5R01HD103721-03R01
Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission
Weill Cornell Medicine
$699.1K
award amount
5P01AI117915-10P01
Early Life Vaccination to Prevent HIV acquisition during Adolescence
Weill Cornell Medicine
$668.2K
award amount
5R38AI174255-02R38
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
Weill Cornell Medicine
$448.9K
award amount
2P01AI129859-07P01
Immunologic strategies to prevent congenital cytomegalovirus transmission and disease in rhesus monkeys
Weill Cornell Medicine
$307.4K
award amount
1R21AI176451-01A1R21
Improving HCMV vaccine-elicited immunity by targeting viral Fc receptors
Weill Cornell Medicine
$247K
award amount
5P01AI178377-02P01
Determinants of HIV broadly-neutralizing antibody precursor induction in infants
University of North Carolina at Chapel Hill
$242.5K
award amount